Related Experiment Video

Updated: Aug 14, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

Preprothyrotropin-releasing hormone mRNA in the rat central gray is strongly and persistently induced during morphine

L G Gahn1, K A Sevarino

  • 1Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Neuropeptides
|June 1, 1996
PubMed

Insights

Thyrotropin-releasing hormone (TRH) plays a key role in the physical symptoms of opiate withdrawal. This study found increased preprothyrotropin-releasing hormone (ppTRH) mRNA in the central gray during morphine withdrawal in rats.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • The central gray region of the brain is implicated in the physical symptoms of opiate withdrawal.
  • Preprothyrotropin-releasing hormone (ppTRH) mRNA is highly expressed in the central gray.
  • Systemic administration of thyrotropin-releasing hormone (TRH) can inhibit the development of opiate dependence in rats.

Purpose of the Study:

  • To investigate the relationship between TRH and opiate withdrawal.
  • To examine the regulation of ppTRH mRNA in the central gray during morphine dependence and withdrawal.

Main Methods:

  • Quantitative in situ hybridization was used to measure ppTRH mRNA levels.
  • Rats were made dependent on morphine and subjected to withdrawal.
  • Specific brain regions, particularly the ventrolateral central gray, were analyzed.

Main Results:

  • A significant increase in ppTRH mRNA was observed in the ventrolateral central gray 3 hours after the onset of withdrawal, persisting for 36 hours.
  • This upregulation was specific to the ventrolateral central gray and was not observed with chronic morphine or acute naltrexone treatment alone.
  • These findings suggest a localized neurochemical change associated with withdrawal.

Conclusions:

  • Thyrotropin-releasing hormone (TRH) or its derived peptides may play a significant role in the central gray during morphine withdrawal.
  • The ventrolateral central gray is a key area involved in the neurobiological response to opiate withdrawal.
  • Further research into TRH-related pathways could offer new therapeutic targets for managing opiate withdrawal symptoms.

More Related Videos

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...